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Abstract
Background: The leading cause of infectious disease death in the United States is communityacquired pneumonia (CAP). Several pneumonia severity indices exist and are widely used as tools
to assist physicians regarding site of care based on risk of death. However, limited data exists that
discerns which of the most commonly used severity scores is the best predictor of mortality across
multiple time points. The objective of this study is to determine the best mortality predictor at different
time points between four of the most commonly used pneumonia severity scores.
Methods: This was a secondary analysis of a prospective, multicenter, population-based,
observational study of patients hospitalized with CAP in the city of Louisville, KY. The severity
indices used were the American Thoracic Society (ATS) criteria, the Pneumonia Severity Index (PSI),
the British Thoracic Society criteria (CURB-65), Quick Sepsis-Related Organ Failure Assessment
(QSOFA), and direct ICU admission to represent physician discretion. The accuracy, kappa statistic,
sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were
calculated for the ability to predict in-hospital, 30-day, 6-month, and 1-year mortality. 95% confidence
intervals for each variable were generated by bootstrapping with random sampling and resampling of
the subjects 1000 times. In addition, the area under the curve (AUC) was calculated for each severity
score and mortality time point.
Results: There were 6013 eligible patients included in this analysis with data collected between the
years 2014 and 2016. At each time point, the QSOFA had the highest sensitivity and NPV, while the
PSI had the highest specificity and PPV. QSOFA had the highest accuracy for in-hospital mortality,
30-day mortality, and 6-month mortality, and the CURB-65 had highest mortality for 1-year mortality.
The QSOFA had the highest kappa statistic for in-hospital mortality, the CURB-65 had the highest
kappa statistic for 30-day mortality, and the PSI had the highest kappa statistic for 6-month and 1-year
mortality. The AUC was highest for the ATS criteria for in-hospital mortality, and was highest for the
PSI at the remaining time points.
Conclusions: The results of this study show that QSOFA and the PSI are the most reliable severity
indices for mortality predictions based on these measures. QSOFA was found, on average, to have
the highest accuracy, sensitivity, and NPV. Additionally, PSI was found, on average, to have the
highest kappa statistic, specificity, and PPV. The AUC, on average, was best with PSI as the predictor.
QSOFA is most capable of making true negative predictions and the PSI is the most capable of
making true positive predictions across the four time points.
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Introduction
The leading cause of infectious disease death in the United
States is community-acquired pneumonia (CAP) [1]. Therefore,
understanding the severity of a specific pneumonia case is
necessary to best direct life-saving treatment. Several indices
have been created to categorize pneumonia cases by their severity
in an ordinal manner. Validation of these severity indices have
been conducted previously by assessing their discriminatory
ability to measure the risk of death in a given population [2].
However, limited data exists that compares multiple severity
indices as tests for mortality prediction. Previous validations
could be the result of confounders for mortality related to the
severity measurements within a given index.

The primary objective of this study is to conduct assessments
of four of the most commonly used pneumonia severity indices
to evaluate their use as mortality predictors at different time
points. The secondary objective of this study is to determine,
which of the four tests is best for making mortality predictions
in a clinical setting before treatment is delivered.
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Table 1 Measurements required for each severity index.

Age
Altered Mental Status
Arterial pH
Blood Pressure
Body Temperature
BUN
Cerebrovascular disease
Congestive Heart Failure
Glucose
Heart Rate
Hematocrit
Leukopenia
Liver Disease
Mechanical Ventilation
Multilobar Infiltrate
Neoplastic Disease
Nursing Home
Oxygen Saturation
PaO2/FiO2
Pleural Effusion
Renal Disease
Respiratory Rate
Septic Shock
Sex
Sodium
Thrombocytopenia
Vasopressors

Table 2 Patient characteristics

ATS PSI CURB-65 QSOFA
x
x
x x
x
x
x
x x
x
x
x x
x x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x x
x
x
x
x
x
x
x

Methods
Study design
This was a secondary analysis of a prospective, multicenter,
population-based, observational study of patients hospitalized
with CAP in the city of Louisville, KY from June 1, 2014 to May
31, 2016 [3].
Subjects
Patients were only eligible for inclusion in this analysis if
1) they were hospitalized for CAP during the study period,
2) pneumonia severity could be assessed for each index, and
3) mortality at each time point was known.
Study Definitions and Measurements
Community-acquired pneumonia: Screenings were
conducted for the primary analysis participation for all
hospitalized adult patients at participating hospitals. Individuals
were asked to participate in the study if they met the following
3 criteria: (1) presence of a new pulmonary infiltrate on chest
radiograph and/or chest computed tomography scan at the
time of hospitalization, defined by a board-certified radiologist’s
reading; (2) at least 1 of the following: (a) new cough or increased
cough or sputum production, (b) fever >37.8°C (100.0°F) or
hypothermia <35.6°C (96.0°F), (c) changes in leukocyte count
(leukocytosis: >11000 cells/μL; left shift: >10% band forms/
mL; or leukopenia: <4000 cells/μL); and (3) no alternative
diagnosis at the time of hospital discharge that justified the
presence of criteria 1 and 2.

Variable
Total n
Demographics
Age, mean (standard deviation)
Male sex, frequency (%)
African American race, frequency (%)
Severity, frequency (%)
Direct ICU admission
One major and/or three minor ATS criteria
PSI risk class IV or V
Curb-65 score 4 or 5
QSOFA score 3
Mortality, frequency (%)
In-hospital mortality
30-day mortality
6-month mortality
1-year mortality

Value
6013
67 (17)
2762 (46)
1205 (20)
1060 (18)
2415 (40)
3711 (62)
975 (16)
475 (8)
426 (7)
835 (14)
1521 (25)
1943 (32)

American Thoracic Society (ATS) Guidelines
List of major and minor criteria for ICU admission intended
primarily for use by emergency medicine physicians,
hospitalists, and primary care practitioners in response to
confusion regarding differences between guidelines for the ATS
and the Infectious Diseases Society of America [4].
Pneumonia Severity Index (PSI)
A clinical prediction rule that considers patient demographics,
comorbidities, physical examination findings, vital signs, and
essential laboratory findings to categorize pneumonia severity
into five risk classes, with categories IV and V having the highest
probability of mortality [5].
British
Thoracic
Society
criteria
(CURB-65)
Severity assessment tool that identifies severe CAP and high
risk mortality in the presence of two or more of the following
features: mental confusion, respiratory rate > 30/min, diastolic
blood pressure < 60 mmHg, and blood urea > 7 mmol/l [6].
Quick Sepsis-Related Organ Failure Assessment
(QSOFA)
Identifies patients with a suspected infection at high risk for
in-hospital mortality outside of the ICU, based on the following
criteria: Respiratory rate ≥ 22/min, mental confusion, and
systolic blood pressure < 100 mm Hg [7].
Definition of Pneumonia Severity
Pneumonia severity was then assessed using 4 severity indices:
American Thoracic Society (ATS) criteria [3], the Pneumonia
Severity Index (PSI) [4], the British Thoracic Society criteria
(CURB-65) [5], Quick Sepsis-Related Organ Failure Assessment
(QSOFA) [6], and direct ICU admission to represent physician
discretion. The measurements associated with each index can
be found in Table 1.
Severity for the ATS criteria was defined as the presence one
major criteria and/or three minor criteria as defined in the
guidelines [3]. Severity for the PSI was defined as risk class IV
or V. Severity for the CURB-65 was defined as a score of 4 or 5.
Severity for the QSOFA was defined as a score of 3.
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Human Subjects Protection
The study was approved by the Institutional Review Board
(IRB) at the University of Louisville Human Subjects Research
Protection Program Office (IRB number 11.0613) and by the
research offices at each participating hospital. The study was
exempt from informed consent.
Statistical Analysis
Descriptive statistics were performed. For each severity index,
severity as defined was used to determine accuracy, the kappa
statistic, sensitivity, specificity, positive predictive value (PPV),
and negative predictive value (NPV) for the ability to predict
in-hospital, 30-day, 6-month, and 1-year mortality. To obtain
95% confidence intervals for each variable, bootstrapping with
random sampling and resampling of the subjects 1000 times
was performed. In addition, the area under the curve (AUC) was
calculated for each severity score using the severity as defined
and each mortality time point.

Results
There were 6013 patients eligible for this analysis. Patient
characteristics, including the number of patients who met
severity as defined, and mortality, are shown in Table 2. For inhospital mortality, the accuracy (0.888), kappa statistic (0.190),
sensitivity (0.238), and NPV (0.935) were highest for QSOFA,
while specificity (0.989) and positive predictive value (0.941)
were highest for the PSI. For 30-day mortality, the accuracy
(0.840), sensitivity (0.274), and NPV (0.943) were highest for
QSOFA, while specificity (0.975) and positive predictive value
(0.932) were highest for the PSI and the kappa statistic (0.237)
was highest for CURB-65. For 6-month mortality, the accuracy
(0.747), sensitivity (0.501), and NPV (0.947) were highest for
QSOFA, while the kappa statistic (0.246), specificity (0.926) and
positive predictive value (0.888) were highest for the PSI. For
1-year mortality, the sensitivity (0.577) and NPV (0.951) were
highest for QSOFA, while the kappa statistic (0.299), specificity
(0.888) and positive predictive value (0.868) were highest for
the PSI and the accuracy (0.700) was highest for CURB-65.
Across the 4 time points, QSOFA was found to most frequently
have the highest accuracy (75%), sensitivity (100%), and NPV
(100%); PSI was found to most frequently have the highest
kappa statistic (50%), specificity (100%), and PPV (100%). The
AUC yielded by severity scores for in-hospital mortality ranged
from 0.600 to 0.693; at one year ranged from 0.546 to 0.685.
The ATS yielded the highest AUC for in-hospital mortality, and
the PSI yielded the highest AUC for mortality at all other time
points. All calculated values can be found in Tables 3-7 and
Figures 1-5.

One important clinical implication is that these severity indices
consistently outperform a physician’s discretion when severity is
determined. However, these indices are used almost exclusively
in research settings and not in a clinical setting. This shows a
need for an index that can predict mortality during the course
of a patient’s hospital stay to better direct medical interventions
and improve health outcomes related to pneumonia.
This data supports the study and creation of these indices.
However, the agreement between severity and mortality is
poor across all indices at each time point, as evidenced by the
low Kappa statistics and AUC values. No AUC went above 0.7,
indicating that alone these severity indexes at a dichotomous
cut-point do not exhibit strong predictive power for predicting
mortality. Also, accuracy decreases as the time increases. This
shows a need for an index that can better predict long-term
mortality with higher accuracy.
Funding Source: Study was supported by the Division of
Infectious Diseases, University of Louisville, Kentucky.
Conflict of Interest: All authors declared no conflict of
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Table 3 Statistical measures for severity indices with in-hospital mortality as the outcome.

Accuracy
Kappa
Sensitivity
Specificity
PPV
NPV

ATS
0.635 (0.623, 0.646)
0.122 (0.106, 0.139)
0.134 (0.121, 0.148)
0.972 (0.966, 0.977)
0.761 (0.720, 0.801)
0.626 (0.613, 0.639)

In Hospital

PSI
0.445 (0.433, 0.458)
0.076 (0.068, 0.085)
0.108 (0.099, 0.118)
0.989 (0.985, 0.993)
0.941 (0.917, 0.962)
0.408 (0.395, 0.420)

CURB65
0.828 (0.818, 0.837)
0.179 (0.149, 0.211)
0.187 (0.161, 0.212)
0.952 (0.946, 0.958)
0.427 (0.381, 0.476)
0.858 (0.849, 0.867)

QSOFA
0.888 (0.880, 0.895)
0.190 (0.154, 0.226)
0.238 (0.199, 0.278)
0.943 (0.938, 0.949)
0.265 (0.221, 0.307)
0.935 (0.929, 0.941)

Direct ICU
0.819 (0.809, 0.829)
0.187 (0.156, 0.216)
0.189 (0.167, 0.212)
0.954 (0.949, 0.960)
0.469 (0.428, 0.515)
0.846 (0.836, 0.856)

QSOFA
0.840 (0.831, 0.849)
0.188 (0.152, 0.220)
0.374 (0.328, 0.420)
0.880 (0.871, 0.888)
0.211 (0.183, 0.238)
0.943 (0.936, 0.949)

Direct ICU
0.785 (0.774, 0.796)
0.195 (0.165, 0.229)
0.287 (0.262, 0.314)
0.892 (0.883, 0.900)
0.363 (0.331, 0.395)
0.854 (0.844, 0.864)

QSOFA
0.747 (0.736, 0.758)
0.134 (0.109, 0.160)
0.501 (0.455, 0.546)
0.768 (0.757, 0.779)
0.156 (0.139, 0.176)
0.947 (0.941, 0.954)

Direct ICU
0.717 (0.705, 0.729)
0.168 (0.139, 0.198)
0.415 (0.385, 0.444)
0.781 (0.771, 0.793)
0.289 (0.269, 0.312)
0.862 (0.851, 0.872)

QSOFA
0.689 (0.679, 0.701)
0.114 (0.093, 0.134)
0.577 (0.532, 0.623)
0.699 (0.687, 0.711)
0.141 (0.125, 0.156)
0.951 (0.944, 0.957)

Direct ICU
0.673 (0.661, 0.685)
0.151 (0.125, 0.176)
0.489 (0.460, 0.517)
0.712 (0.701, 0.725)
0.267 (0.247, 0.286)
0.867 (0.856, 0.877)

Table 4 Statistical measures for severity indices with 30-day mortality as the outcome.

Accuracy
Kappa Stat
Sensitivity
Specificity
PPV
NPV

ATS
0.654 (0.641, 0.666)
0.194 (0.172, 0.215)
0.244 (0.227, 0.261)
0.930 (0.921, 0.938)
0.699 (0.667, 0.731)
0.647 (0.634, 0.660)

30 Days

PSI
0.504 (0.491, 0.517)
0.151 (0.139, 0.164)
0.211 (0.199, 0.224)
0.975 (0.969, 0.981)
0.932 (0.915, 0.948)
0.434 (0.420, 0.447)

CURB65
0.804 (0.796, 0.815)
0.237 (0.207, 0.269)
0.327 (0.296, 0.358)
0.896 (0.888, 0.904)
0.378 (0.343, 0.413)
0.874 (0.864, 0.883)

Table 5 Statistical measures for severity indices with 6-month mortality as the outcome.

Accuracy
Kappa Stat
Sensitivity
Specificity
PPV
NPV

ATS
0.653 (0.642, 0.665)
0.231 (0.207, 0.256)
0.383 (0.363, 0.401)
0.834 (0.823, 0.846)
0.608 (0.584, 0.634)
0.668 (0.654, 0.682)

PSI
0.579 (0.567, 0.592)
0.246 (0.228, 0.263)
0.364 (0.349, 0.379)
0.926 (0.915, 0.937)
0.888 (0.871, 0.904)
0.475 (0.460, 0.489)

6 Months

CURB65
0.745 (0.734, 0.757)
0.236 (0.206, 0.265)
0.496 (0.465, 0.527)
0.794 (0.784, 0.805)
0.318 (0.296, 0.341)
0.890 (0.881, 0.899)

Table 6 Statistical measures for severity indices with 1-year mortality as the outcome.

Accuracy
Kappa Stat
Sensitivity
Specificity
PPV
NPV

ATS
0.645 (0.633, 0.657)
0.238 (0.213, 0.261)
0.461 (0.443, 0.481)
0.769 (0.756, 0.783)
0.573 (0.551, 0.595)
0.680 (0.666, 0.695)

PSI
0.620 (0.609, 0.633)
0.299 (0.281, 0.320)
0.454 (0.439, 0.470)
0.888 (0.875, 0.901)
0.868 (0.853, 0.883)
0.502 (0.487, 0.518)

1 Year

CURB65
0.700 (0.690, 0.712)
0.212 (0.189, 0.238)
0.572 (0.542, 0.604)
0.725 (0.713, 0.738)
0.287 (0.267, 0.308)
0.898 (0.888, 0.907)

Table 7 Area under the curve (AUC) for mortality outcomes with severity indices as the predictor.

In-Hospital
30 Day
6 Month
1 Year

ATS
0.693
0.673
0.638
0.626

Area Under the Curve (AUC)

PSI
0.674
0.683
0.681
0.685

CURB65
0.643
0.626
0.604
0.592
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QSOFA
0.600
0.577
0.552
0.546

Direct ICU
0.658
0.608
0.576
0.567
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Figure 1 Accuracy of severity models

Figure 4 Specificity of severity models

Figure 2 Kappa statistic of severity models

Figure 5 Positive predictive value of severity models

Figure 3 Sensitivity of severity models

Figure 6 Negative predictive value of severity models
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